Juvenile sexual offending is increasingly being recognized as a serious crime among youth. The prevalence of sexual offending and sexual reoffending suggests that many juvenile sex offenders (JSOs) may repeat their offending behaviors if not treated. However, clinical trials evaluating specific interventions are virtually nonexistent. Instead, the literature on the treatment of JSOs is marked by discussions of strategies that are hypothesized to be beneficial, as well as descriptions of treatment programs that exist across the country. Further, while existing literature suggests that treatment for JSOs may deter future sexual offending behaviors, it is unclear which, if any, aspects of these treatments promote the development of positive behaviors. A discussion of existing treatment approaches, effectiveness, and treatment considerations follows.
The majority of research that exists studying juvenile sex offenders (JSOs) is dominated by the predilection that identifying risk factors associated with recidivism will benefit both the JSOs and treatment providers. Further, the majority of existing treatments are guided by research that has identified what makes JSOs more likely to reoffend. Absent from the majority of the literature is an examination of the strengths and positive characteristics demonstrated by JSOs that may prove useful in both reducing recidivism and increasing the likelihood of achieving positive outcomes (i.e., demonstrating resilience). Research examining known risk factors for sexual and nonsexual recidivism is described. Next, literature on resilience is reviewed, followed by a discussion of this literature in the context of treatment for JSOs. Finally, future directions of research are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.